TPT1 and breast carcinoma: DNA methyl transferase inhibitors reverse epigenetic alterations, resulting in reactivation of tumor suppressor genes, which in turn leads to cell cycle arrest and/or apoptosis, and thus suggests that re-expression of TPT1-AS1 could be an approach to be pursued in breast cancer therapy.